ALZHEIMER DISEASE, EARLY ONSET
Clinical trials for ALZHEIMER DISEASE, EARLY ONSET explained in plain language.
Never miss a new study
Get alerted when new ALZHEIMER DISEASE, EARLY ONSET trials appear
Sign up with your email to follow new studies for ALZHEIMER DISEASE, EARLY ONSET, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Alzheimer's drug enters early human testing
Disease control Recruiting nowThis study tests an experimental drug called DNL628 in people with early Alzheimer's disease. The main goal is to check if the drug is safe and how the body processes it. About 68 participants will receive either the drug or a placebo. This is an early-stage trial, so it focuses …
Matched conditions: ALZHEIMER DISEASE, EARLY ONSET
Phase: PHASE1 • Sponsor: Denali Therapeutics Inc. • Aim: Disease control
Last updated May 17, 2026 02:41 UTC
-
New Alzheimer's drug enters human trials: could it slow memory loss?
Disease control Recruiting nowThis study is testing an experimental drug called ARO-MAPT-SC in healthy volunteers and people with early Alzheimer's disease. The goal is to see if the drug is safe and how the body processes it. The drug works by targeting a protein linked to Alzheimer's, with the hope of slowi…
Matched conditions: ALZHEIMER DISEASE, EARLY ONSET
Phase: PHASE1, PHASE2 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Could flickering lights and sounds slow Alzheimer's? MIT launches new trial.
Disease control Recruiting nowThis study tests whether using a special device that flashes light and plays sound at 40 times per second can help people with mild Alzheimer's. Sixty participants will use the device at home for one hour each day for six months. Researchers will check brain activity, memory, and…
Matched conditions: ALZHEIMER DISEASE, EARLY ONSET
Phase: NA • Sponsor: Massachusetts Institute of Technology • Aim: Disease control
Last updated May 04, 2026 16:18 UTC
-
Zapping the brain to fight forgetfulness and depression in dementia
Symptom relief Recruiting nowThis study tests whether a gentle, non-invasive brain stimulation (tDCS) combined with cognitive training can improve memory, thinking, and mood in people with mild cognitive impairment or early-stage dementia. Fifty participants will receive both real and placebo stimulation in …
Matched conditions: ALZHEIMER DISEASE, EARLY ONSET
Phase: NA • Sponsor: University of Campania Luigi Vanvitelli • Aim: Symptom relief
Last updated May 17, 2026 02:44 UTC
-
New Alzheimer's drug enters early safety testing
Symptom relief Recruiting nowThis study tests a new drug called THN391 in people with early Alzheimer's disease. The main goal is to check if the drug is safe and how it works in the body. Fifteen participants will receive either the drug or a placebo over about 6 months. This is an early-stage study, so it …
Matched conditions: ALZHEIMER DISEASE, EARLY ONSET
Phase: PHASE1 • Sponsor: Therini Bio, Inc. • Aim: Symptom relief
Last updated May 15, 2026 11:53 UTC
-
Alzheimer's drug vs. brain training: which works better?
Symptom relief Recruiting nowThis study compares two approaches for treating early Alzheimer's disease: the drug donepezil versus non-drug cognitive therapy. About 240 newly diagnosed adults aged 50 and older will be randomly assigned to one of the two groups for 6 months. The goal is to see which approach b…
Matched conditions: ALZHEIMER DISEASE, EARLY ONSET
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated May 11, 2026 20:40 UTC
-
Brain training and tai chi tested as new weapons against early Alzheimer's
Symptom relief Recruiting nowThis study looks at whether computerized cognitive training and Tai Chi-Qi Gong exercises can help people with early-onset Alzheimer's disease. Researchers will compare these activities to a control group to see if they improve memory, thinking, and mood. The study involves 60 pa…
Matched conditions: ALZHEIMER DISEASE, EARLY ONSET
Phase: NA • Sponsor: Indiana University • Aim: Symptom relief
Last updated May 05, 2026 11:52 UTC
-
New brain scan could detect Alzheimer's years earlier
Knowledge-focused Recruiting nowThis study tests a new, non-invasive MRI technique to detect early brain changes linked to Alzheimer's disease in 50 adults aged 50-80 with mild memory concerns. Researchers will compare brain scans of participants with healthy controls to see if this method can identify those at…
Matched conditions: ALZHEIMER DISEASE, EARLY ONSET
Phase: NA • Sponsor: Rennes University Hospital • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC
-
New brain scan method could spot Alzheimer's and Parkinson's early
Knowledge-focused Recruiting nowThis study is testing whether a new, low-cost brain scan can find early signs of Alzheimer's and Parkinson's disease. Researchers will compare brain scans from 120 people, including those at risk for Alzheimer's, those with Parkinson's, and healthy volunteers. The goal is to deve…
Matched conditions: ALZHEIMER DISEASE, EARLY ONSET
Phase: NA • Sponsor: Rennes University Hospital • Aim: Knowledge-focused
Last updated May 05, 2026 11:55 UTC